The PCR technologies market size is projected to reach US$ 24,524.50 million by 2030 from US$ 13,101.87 million in 2022. The market is expected to register a CAGR of 8.2% during 2022–2030. The advancements in PCR technologies are likely to serve as one of the key trends in the market.
Factors driving the PCR technologies market growth are the rise in the incidence of target infectious diseases and genetic disorders, continual improvements in PCR technologies, and growing funding and investments. Furthermore, rising market penetration in emerging nations is likely to provide growth opportunities for market players in the PCR technologies market. PCR has evolved significantly over the years, resulting in the creation of faster, more sensitive, and highly efficient PCR methods. These breakthroughs include real-time PCR, digital PCR, and multiplex PCR, among others. Each iteration brings enhancement in speed, accuracy, and the capacity to detect many targets simultaneously, therefore broadening its applications in diagnostics and research, which is likely to boost the growth of the PCR technologies market.
The use of PCR technology is being explored in several nonconventional applications, making molecular diagnosis more accessible and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The ultrafast PCR reduces the test duration by ten times compared to the previous tests by utilizing photothermal nanomaterials. In addition, the rise in the development of personalized medicine owing to the availability of particular genome testing and the developing field of nutrigenomics are fueling the growth of the market.
Government and federal agencies around the world are progressively acknowledging the relevance of qPCR and dPCR products in genomics research. In the recent decade, the market has seen several funding programs to boost genomic research from both government and private institutions. Visby Medical (US), an infectious disease diagnostic business, obtained Phase 2 funding from the National Institutes of Health under its Rapid Acceleration of Diagnostics initiative in October 2020. EVONETIX LTD announced the completion of its Series B financing round in 2020. The company, led by new investor Foresite Capital, raised US$ 30 million (£23 million) in this round. These initiatives aim to conduct medical genomics-based investigations in customized medicine, such as PCR-based disease detection and treatment. Thus, with the increasing availability of financial support for maintaining R&D in disease-targeted genomics research activities, the need for PCR products is expected to increase, thereby driving market growth.
In recent years, molecular methods such as PCR have progressed as diagnostic tools, enabling healthcare professionals to accurately diagnose various infectious diseases. PCR techniques are also being widely accepted and utilized in emerging countries. According to the World Health Organization (WHO) Report on the Establishment of PCR Laboratory in Developing Countries, WHO provides technical assistance to establish PCR laboratories in all 11 WHO Southeast Asia countries. Depending on their need, these facilities have adopted various PCR technologies such as reverse transcriptase PCR (RT-PCR), multiplex PCR, real-time PCR, in-situ PCR, and dPCR. The application of PCR technologies is increasing in clinical microbiology, biotechnology, virology, parasitology, and allied fields due to this tool's simple, rapid, and highly specific screening. Thus, the PCR technologies market in developing countries is expected to offer lucrative opportunities during the forecast period.
Key segments that contributed to the derivation of the PCR technologies market analysis are technology, offerings, application, and end user.
The geographic scope of the PCR technologies market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the PCR technologies market. The market growth in this region is attributed to the rising demand for state-of-the-art products from bioanalytical instrument manufacturers and PCR companies, extensive R&D conducted across various academic and research institutes, and the presence of significant market players. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries. An upsurge in the acceptance and implementation of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. Further, Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the PCR Technologies Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses PCR Technologies Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 13,101.87 Million |
| Market Size by 2030 | US$ 24,524.50 Million |
| Global CAGR (2022 - 2030) | 8.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The PCR Technologies Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the PCR Technologies Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The PCR technologies market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the PCR technologies market are listed below:
The “PCR Technologies Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
The List of Companies - PCR Technology Market
North America region dominated the PCR technologies market in 2022.
The rising prevalence of genetic and infectious diseases and rising investments and funds availability for PCR technologies are the most influential factors responsible for market growth.
Atila Biosystems; Thermo Fisher Scientific, Inc.; Takara Bio Inc.; Standard BioTools Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc; Agilent Technologies; Biomerieux SA; QIAGEN NV; Promega Corporation; Becton, Dickinson, and Company; Visby Medical, Inc.; and Ellume Ltd are the market players in the PCR technologies market.
The estimated value of the PCR technologies market accounted for US$ 24,524.50 million in 2030.
The global PCR technologies market is estimated to register a CAGR of 8.2% during the forecast period 2022–2030.